Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2011

ROCKVILLE, Md.--(BUSINESS WIRE)--Mar. 8, 2012-- Emergent BioSolutions Inc. (NYSE: EBS) announced today its financial results for the fourth quarter and full year ended December 31, 2011. Total revenues for 2011 were $273.4 million as compared to $286.2 million in 2010, and net income for 2011 was $23.0 million, or $0.65 per basic share, as compared to $51.7 million, or $1.63 per basic share, in 2010.

NATO Emerging Security Challenges Division Partners with Emergent BioSolutions to Host Biopreparedness Workshop at the Counter Terror Expo in London

ROCKVILLE, Md., Apr 26, 2012 (BUSINESS WIRE) --Emergent BioSolutions Inc. (NYSE:EBS) today announced its support of the North Atlantic Treaty Organization (NATO) Emerging Security Challenges Division (ESCD) in hosting a biopreparedness workshop entitled "A Bio-Attack: Are We Prepared?" The workshop aims to evaluate and strengthen NATO's strategies and capabilities in managing consequences of potential chemical, biological, radiological, and nuclear attacks.

Investigators

Emergent Investigator Community
To join the Emergent investigator community, please fill out and submit the form below:

 
 

Pages

Subscribe to Emergent RSS